Approval · Notice of Compliance 1861 · 1999
IPRATROPIUM: Notice of Compliance 1861
Issued June 29, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1861
- Date
- June 29, 1999
- Company
- Pharmel Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New dosage form and strength
- Therapeutic class
- Topical anticholinergic for nasal administration
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPRATROPIUM | 02240474 | Cancelled Pre Market |
Medicinal ingredients
- IPRATROPIUM BROMIDE 0.3 MG per ML